| Name |
Date |
Price (USD) |
Description |
|
Abbott Laboratories: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Abbott in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Amgen Inc: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Amgen in the
ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Astellas Pharma Inc: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Astellas in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
AstraZeneca Plc (incl MedImmune Inc): PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for AstraZeneca
in the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Bayer Schering Pharma AG: PharmaVitae Profile |
12-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Bayer Schering
in the ethical pharma sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Boehringer Ingelheim GmbH: PharmaVitae Profile |
25-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Boehringer
Ingelheim in the ethical pharma sector. The profile encompasses global company
strategy, portfolio and pipeline analysis and assessment of financial performance,
with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Bristol-Myers Squibb Co: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for BMS in the
ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Bristol-Myers Squibb Co: PharmaVitae Profile |
30-Mar-07 |
5700 |
This analysis examines the historical and forecast performance for BMS in the
ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Eli Lilly & Co: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Eli Lilly
in the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Genentech: PharmaVitae Profile |
18-Oct-07 |
5700 |
This analysis examines the historical and forecast performance for Genentech
in the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
GlaxoSmithKline Plc: PharmaVitae Profile |
14-Nov-07 |
5700 |
This analysis examines the historical and forecast performance for GSK in the
ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Johnson & Johnson: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for J&J in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Merck & Co Inc: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Merck &
Co. in the ethical pharmaceutical sector. The profile encompasses global company
strategy, portfolio and pipeline analysis and assessment of financial performance,
with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Novartis AG: PharmaVitae Profile |
13-Nov-07 |
5700 |
This analysis examines the historical and forecast performance for Novartis in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Pfizer Inc: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Pfizer in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Roche: PharmaVitae Profile |
18-Oct-07 |
5700 |
This analysis examines the historical and forecast performance for Roche in the
ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Sanofi-Aventis: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Sanofi-Aventis
in the ethical pharma sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Schering-Plough Corporation: PharmaVitae Profile
|
14-Nov-07 |
5700 |
This analysis examines the historical and forecast performance for Schering-Plough
in the ethical pharmaceutical sector. It encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Takeda Pharmaceutical Co Ltd: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Takeda in
the ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
|
Teva: PharmaVitae Generics Profile |
31-Jul-07 |
3800 |
This analysis examines the historical and forecast performance for Teva in the
generic pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key branded drugs. An interactive data and analysis
tool provides additional quantitative and qualitative information. |
|
Wyeth: PharmaVitae Profile |
19-Dec-07 |
5700 |
This analysis examines the historical and forecast performance for Wyeth in the
ethical pharmaceutical sector. The profile encompasses global company strategy,
portfolio and pipeline analysis and assessment of financial performance, with
1-6 year sales forecasts for key drugs. An interactive forecasting and analysis
tool provides continually updated quantitative and qualitative information. |
